## PM: Philip Morris International Inc - XLP: Consumer Defensive

### Executive Summary

VALUE thesis: PEG 1.01 indicates fundamental undervaluation. Quality metrics strong (ROA 15%). Consistent execution (4/4 quarters beat estimates). Caution: momentum weakening (-5.3% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($147.70)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. The Zacks Analyst Blog Highlights Palantir Technologies, Philip Morris International, TotalEnergies, Natural Resource Partners and Genie Energy**
- Source: Yahoo Finance | 20251202T153200 | Somewhat-Bullish | Relevance: 100%
-  This Zacks Analyst Blog highlights research reports on Palantir Technologies, Philip Morris International, TotalEnergies, Natural Resource Partners, and Genie Energy. It discusses the financial performance, strategic initiatives, and market outlook for each company, including their strengths, risks, and analyst ratings. The article also provides insight into the "Ahead of Wall Street" daily article and Zacks' overall stock-picking strategies.

**2. Groupama Asset Managment Grows Position in Philip Morris International Inc. $PM**
- Source: MarketBeat | 20251130T095131 | Somewhat-Bullish | Relevance: 99%
- Groupama Asset Managment significantly increased its stake in Philip Morris International Inc. by 36.5% in Q2 2025, bringing its total holdings to 21,854 shares. This move is part of a broader trend of institutional investors growing their positions in PM, which currently has a market capitalization of $244.78 billion and a "Moderate Buy" consensus rating from analysts with an average price target of $189. The company also recently raised its quarterly dividend to $1.47, yielding 3.7%.

**3. Philip Morris International Presents at 2025 Morgan Stanley Global Consumer & Retail Conference**
- Source: Business Wire | 20251202T120150 | Somewhat-Bullish | Relevance: 99%
- Philip Morris International (PMI) CEO Jacek Olczak will address investors at the Morgan Stanley Global Consumer & Retail Conference, where the company will reaffirm its 2025 full-year reported diluted EPS forecast of $7.39 to $7.49. This forecast represents a projected increase of 13.5% to 15.1% versus adjusted diluted EPS of $6.57 in 2024, emphasizing the company's commitment to its smoke-free future strategy and financial performance. The article also provides detailed financial adjustments and forward-looking statements regarding potential risks and opportunities.

**4. STOP report response | PMI**
- Source: Philip Morris International | 20251201T230810 | Somewhat-Bullish | Relevance: 99%
- Philip Morris International (PMI) addresses a 60+ page report from "Stopping Tobacco Organizations & Products" (STOP), refuting its allegations. PMI asserts the STOP report contains outdated, misleading, or irrelevant information, including misattributions and claims about cigarette sales and the impact of smoke-free products. PMI defends its commitment to a smoke-free future, its scientific endeavors, and its marketing practices, accusing STOP of fearmongering and censorship.

**5. Top Analyst Reports for Palantir, Philip Morris & TotalEnergies**
- Source: Yahoo Finance Singapore | 20251201T212100 | Somewhat-Bullish | Relevance: 99%
- This article presents Zacks Research Daily's top analyst reports on 16 major stocks, including Palantir Technologies, Philip Morris International, and TotalEnergies SE, along with two micro-cap stocks. It details the performance, strategic initiatives, and challenges of these companies, providing insights from Zacks' analyst team. The featured reports cover various aspects like AI strategy, smoke-free product expansion, clean energy investments, and market risks.

### Analyst Activity

**Target Signal:** BEARISH (Raises: 0, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-26 | JP Morgan | $185 | $190 | -3% |
| 2025-11-17 | Barclays | $180 | $220 | -18% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-26 | JP Morgan | main | Overweight |
| 2025-11-17 | Barclays | main | Overweight |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 51.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 9 / 1 |

**Top Holders:**
- Vanguard Group Inc: 9.2% (+0.4%)
- Capital World Invest: 8.3% (+2.1%)
- Blackrock Inc.: 6.8% (+1.6%)
- JPMORGAN CHASE & CO: 6.1% (+105.8%)
- Capital Internationa: 5.7% (+1.0%)

### Key Risks

1. Long-term trend broken: trading 5.8% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.01 suggests fair value with growth premium. Quality metrics strong (ROA 15%, margin 22%). Balance sheet: strong liquidity (2.8x), $4.1B free cash flow. Analyst sentiment negative (2 target cuts vs 0 raises). Institutional flow bullish (9 buying vs 1 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $233.1B |
| Beta | 0.44 |
| 52W Range | $116.12 - $186.69 |
| Short Interest | 1.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.01 |
| Forward P/E | 18.5 |
| Current P/E | 20.5 |
| YoY Growth | 10.4% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 3.8% to -1.5% (-5.3% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.5pp (needs >4.0% for momentum thesis). Below SMA200 (0.94x), long-term trend not supportive. RSI neutral at 50.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.53% (CS: 40) | Neutral |
| RSI_14 | 49.5 | Neutral |
| MACD Histogram | 0.36 | Bullish |
| vs SMA20 | 1.002x | Above |
| vs SMA50 | 0.994x | Below |
| vs SMA200 | 0.942x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $154.62
- **Stop Loss:** $147.70 (4.5% risk)
- **Target:** $168.46 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 144
- **Position Value:** $22,265.28
- **Portfolio %:** 22.27%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate improvement trajectory. VIX compression from 20.5 to 16.6 over 5 days signals declining fear, while 47% breadth shows narrow but recovering participation. Fed meeting in 6 days creates near-term uncertainty, but AI sector momentum and improving technical setups support selective positioning.*

### Earnings

**Next:** 2026-02-05 (Est: $1.71)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.10 | $2.24 | +6.9% |
| 2025Q2 | $1.86 | $1.91 | +2.8% |
| 2025Q1 | $1.61 | $1.69 | +4.8% |
| 2024Q4 | $1.50 | $1.55 | +3.4% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*